|
1
|
Hill MK, Archibald AD, Cohen J and
Metcalfe SA: A systematic review of population screening for
fragile X syndrome. Genet Med. 12:396–410. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Winarni Indah T, Chonchaiya W, Adams E, Au
J, Mu Y, Rivera SM, Nguyen DV and Hagerman RJ: Sertraline may
improve language developmental trajectory in young children with
fragile × syndrome: A retrospective chart review. Autism Res Treat.
2012:1043172012.PubMed/NCBI
|
|
3
|
Visootsak J, Warren ST, Anido A and Graham
JM Jr: Fragile X syndrome: An update and review for the primary
pediatrician. Clin Pediatr (Phila). 44:371–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferreira GC and Lamonica DA: Language
characterization in the X-fragile syndrome: A review study. Pro
Fono. 17:111–120. 2005.(In Portuguese). PubMed/NCBI
|
|
5
|
Kidd SA, Lachiewicz A, Barbouth D, Blitz
RK, Delahunty C, McBrien D, Visootsak J and Berry-Kravis E: Fragile
X syndrome: A review of associated medical problems. Pediatrics.
134:995–1005. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cowley B, Kirjanen S, Partanen J and
Castrén ML: Epileptic electroencephalography profile associates
with attention problems in children with fragile X syndrome: Review
and case series. Front Hum Neurosci. 10:3532016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McCary LM and Roberts JE: Early
identification of autism in fragile X syndrome: A review. J
Intellect Disabil Res. 57:803–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ciaccio C, Fontana L, Milani D, Tabano S,
Miozzo M and Esposito S: Fragile X syndrome: A review of clinical
and molecular diagnoses. Ital J Pediatr. 43:392017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lozano R, Azarang A, Wilaisakditipakorn T
and Hagerman RJ: Fragile X syndrome: A review of clinical
management. Intractable Rare Dis Res. 5:145–157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Essop FB and Krause A: Diagnostic, carrier
and prenatal genetic testing for fragile X syndrome and other
FMR-1-related disorders in Johannesburg, South Africa: A 20-year
review. S Afr Med J. 103 12 Suppl 1:S994–S998. 2013. View Article : Google Scholar
|
|
11
|
Rueda JR, Ballesteros J and Tejada MI:
Systematic review of pharmacological treatments in fragile X
syndrome. BMC Neurol. 9:532009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xunclà M, Badenas C, Domínguez M,
Rodríguez-Revenga L, Madrigal I, Jiménez L, Soler A, Borrell A,
Sánchez A and Milà M: Fragile X syndrome prenatal diagnosis:
Parental attitudes and reproductive responses. Reprod Biomed
Online. 21:560–565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Romero-Espinoza P, Rosales-Reynoso MA,
Willemsen R and Barros-Nunez P: FMR1 protein expression in blood
smears for fragile X syndrome diagnosis in a Mexican population
sample. Genet Test Mol Biomarkers. 14:511–514. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leehey MA: Fragile X-associated
tremor/ataxia syndrome: Clinical phenotype, diagnosis, and
treatment. J Investig Med. 57:830–836. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen M, Zhao M, Lee CG and Chong SS:
Identification of microsatellite markers <1 Mb from the FMR1 CGG
repeat and development of a single-tube tetradecaplex PCR panel of
highly polymorphic markers for preimplantation genetic diagnosis of
fragile X syndrome. Genet Med. 18:869–875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang WC, Chou YP, Kao PM, Hsu TK, Su HC,
Ho YN, Yang YC and Hsu BM: Nested-PCR and TaqMan real-time
quantitative PCR assays for human adenoviruses in environmental
waters. Water Sci Technol. 73:1832–1841. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rajan-Babu IS, Law HY, Yoon CS, Lee CG and
Chong SS: Simplified strategy for rapid first-line screening of
fragile X syndrome: Closed-tube triplet-primed PCR and amplicon
melt peak analysis. Expert Rev Mol Med. 17:e72015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malcov M, Naiman T, Yosef DB, Carmon A,
Mey-Raz N, Amit A, Vagman I and Yaron Y: Preimplantation genetic
diagnosis for fragile X syndrome using multiplex nested PCR. Reprod
Biomed Online. 14:515–521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Curtis-Cioffi KM, Rodrigueiro DA,
Rodrigues VC, Cicarelli RM and Scarel-Caminaga RM: Comparison
between the polymerase chain reaction-based screening and the
Southern blot methods for identification of fragile X syndrome.
Genet Test Mol Biomarkers. 16:1303–1308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosales-Reynoso MA, Vilatela EA, Ojeda RM,
Arce-Rivas A, Sandoval L, Troyo-Sanromán R and Barros-Núñez P: PCR
approach for detection of fragile X syndrome and Huntington disease
based on modified DNA: Limits and utility. Genet Test. 11:153–159.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vaughan MJ, Chanon A and Blakeslee JJ:
Using capillary electrophoresis to quantify organic acids from
plant tissue: A test case examining coffea arabica seeds. J Vis
Exp. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hagerman R and Hagerman P: Advances in
clinical and molecular understanding of the FMR1 premutation and
fragile X-associated tremor/ataxia syndrome. Lancet Neurol.
12:786–798. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang JY, Hessl D, Schneider A, Tassone F,
Hagerman RJ and Rivera SM: Fragile X-associated tremor/ataxia
syndrome: Influence of the FMR1 gene on motor fiber tracts in males
with normal and premutation alleles. JAMA Neurol. 70:1022–1029.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Godler DE, Inaba Y, Schwartz CE, Bui QM,
Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman RJ, Francis D, et al:
Detection of skewed X-chromosome inactivation in Fragile X syndrome
and X chromosome aneuploidy using quantitative melt analysis.
Expert Rev Mol Med. 17:e132015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo S, Huang W, Xia Q, Xia Y, Du Q, Wu L
and Duan R: Cryptic FMR1 mosaic deletion in a phenotypically normal
mother of a boy with fragile X syndrome: Case report. BMC Med
Genet. 15:1252014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wilkinson R, Wang X, Kassianos AJ, Zuryn
S, Roper KE, Osborne A, Sampangi S, Francis L, Raghunath V and
Healy H: Laser capture microdissection and multiplex-tandem PCR
analysis of proximal tubular epithelial cell signaling in human
kidney disease. PLoS One. 9:e873452014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vignini A, Morganti S, Salvolini E,
Sartini D, Luzzi S, Fiorini R, Provinciali L, Di Primio R, Mazzanti
L and Emanuelli M: Amyloid precursor protein expression is enhanced
in human platelets from subjects with Alzheimer's disease and
frontotemporal lobar degeneration: A real-time PCR study. Exp
Gerontol. 48:1505–1508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Filipovic-Sadic S, Sah S, Chen L, Krosting
J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ
and Tassone F: A novel FMR1 PCR method for the routine detection of
low abundance expanded alleles and full mutations in fragile X
syndrome. Clin Chem. 56:399–408. 2010.PubMed/NCBI
|
|
29
|
Christofolini DM, Lipay MV, Ramos MA,
Brunoni D and Melaragno MI: Screening for fragile X syndrome among
Brazilian mentally retarded male patients using PCR from buccal
cell DNA. Genet Mol Res. 5:448–453. 2006.PubMed/NCBI
|
|
30
|
Chow JC, Chen DJ, Lin CN, Chiu CY, Huang
CB, Chiu PC, Lin CH, Lin SJ and Tzeng CC: Feasibility of blood spot
PCR in large-scale screening of fragile X syndrome in southern
Taiwan. J Formos Med Assoc. 102:12–16. 2003.PubMed/NCBI
|
